These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10897982

  • 21. [Obsessive psychotic disorder in adolescence].
    De Lucas Taracena MT, Zubeldia V, Fernández Alvarez MA, Asenjo Rodríguez E.
    Actas Esp Psiquiatr; 2000; 28(6):399-401. PubMed ID: 11262286
    [Abstract] [Full Text] [Related]

  • 22. Obsessive-compulsive disorder.
    Insel TR.
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [Abstract] [Full Text] [Related]

  • 23. Treatment of obsessive-compulsive disorder in children and adolescents.
    Rapoport JL, Inoff-Germain G.
    J Child Psychol Psychiatry; 2000 May; 41(4):419-31. PubMed ID: 10836672
    [Abstract] [Full Text] [Related]

  • 24. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ, Wisman PW.
    Tijdschr Psychiatr; 2007 May; 49(5):315-25. PubMed ID: 17492582
    [Abstract] [Full Text] [Related]

  • 25. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B.
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [Abstract] [Full Text] [Related]

  • 26. Obsessive-compulsive disorder: identification, neurobiology, and treatment.
    Neel JL, Stevens VM, Stewart JE.
    J Am Osteopath Assoc; 2002 Feb; 102(2):81-6. PubMed ID: 11866396
    [Abstract] [Full Text] [Related]

  • 27. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.
    Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB.
    J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635
    [Abstract] [Full Text] [Related]

  • 29. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [Abstract] [Full Text] [Related]

  • 30. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 31. Out-patient, multi-modal behaviour therapy for obsessive-compulsive disorder.
    Hand I.
    Br J Psychiatry Suppl; 1998 Apr; (35):45-52. PubMed ID: 9829026
    [Abstract] [Full Text] [Related]

  • 32. [Ambulatory behavior therapy in obsessive-compulsive disorders].
    Hand I.
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():12-8. PubMed ID: 7635389
    [Abstract] [Full Text] [Related]

  • 33. Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.
    J Clin Psychiatry; 1997 Jun; 58 Suppl 4():2-72. PubMed ID: 9183300
    [No Abstract] [Full Text] [Related]

  • 34. Current issues in the treatment of OC-spectrum conditions.
    Wetterneck CT, Teng EJ, Stanley MA.
    Bull Menninger Clin; 2010 Jun; 74(2):141-66. PubMed ID: 20545493
    [Abstract] [Full Text] [Related]

  • 35. Cognitive behavior therapy for obsessive-compulsive and related disorders.
    Lewin AB, Wu MS, McGuire JF, Storch EA.
    Psychiatr Clin North Am; 2014 Sep; 37(3):415-45. PubMed ID: 25150570
    [Abstract] [Full Text] [Related]

  • 36. [Behavior therapy of obsessive compulsive disorders].
    Légeron P, Wajsgros A.
    Encephale; 1989 Sep; 15(3):343-50. PubMed ID: 8641161
    [Abstract] [Full Text] [Related]

  • 37. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
    Towbin KE, Leckman JF, Cohen DJ.
    Psychiatr Dev; 1987 Sep; 5(1):25-50. PubMed ID: 2885832
    [Abstract] [Full Text] [Related]

  • 38. Obsessive-compulsive disorder. How to free patients from intrusive thoughts and rituals.
    Pary R, Lippmann S, Tobias CR.
    Postgrad Med; 1994 Dec; 96(8):119-25. PubMed ID: 7991473
    [Abstract] [Full Text] [Related]

  • 39. Behavioral and pharmacological treatments for tic and habit disorders: a review.
    Peterson AL, Campise RL, Azrin NH.
    J Dev Behav Pediatr; 1994 Dec; 15(6):430-41. PubMed ID: 7884015
    [Abstract] [Full Text] [Related]

  • 40. [Combination of several psychotherapeutic methods including psychopharmaceuticals. A case of obsessive-compulsive disorder].
    Irgens A.
    Tidsskr Nor Laegeforen; 1997 Apr 10; 117(9):1314-5. PubMed ID: 9182364
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.